Evidence map›Paper›PMID 28423337›Full record

ReviewImmunity2017

Homeostatic Immunity and the Microbiota.

Yasmine Belkaid, Oliver J Harrison

3 registry-linked trialsAbstract readReview
In one paragraph

Review in Immunity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 713 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
713citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04046432 nacompletednot on this map

Effects of Vigiis 101-LAB on Gut Health

TypeinterventionalSponsorSunWay Biotech Co., LTD.Ran2017 to 2018Enrolled54ConditionsGastrointestinal MicrobiomeArmsVigiis 101-LAB, Placebo
NCT04088474 nacompletednot on this map

Functional Assessment in The Intestinal Flora Improvement

TypeinterventionalSponsorSunWay Biotech Co., LTD.Ran2016 to 2016Enrolled36ConditionsGastrointestinal MicrobiomeArmsVigiis 101-LAB, Placebo
NCT04662619 nacompletednot on this mapstarted 2020, after this paper: background citation

A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Parallel-Group, Nutritional Intervention Study to Examine the Clinical and Immunological Effects of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis

TypeinterventionalSponsorJohnson & Johnson Consumer Inc. (J&JCI)Ran2020 to 2024Enrolled273ConditionsHealthyArmsB. infantis, Lactose Placebo
3 · Its place in the literature

Who cites it

713 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Gut microbes · 2026
    Article
  7. Gut microbes · 2026
    Article
  8. Review
  9. Review
  10. Gut microbes · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Vaginal Microbiota and Pelvic Floor Dysfunction: Mechanistic Insights and Therapeutic Implications.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  20. Review

653 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yasmine BelkaidMucosal Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA; NIAID Microbiome Program, NIH, Bethesda, MD 20892, USA. Electronic address: ybelkaid@niaid.nih.gov.
Oliver J HarrisonMucosal Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.

Funding

Role of the microbiota in immunityZIAAI001115 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BELKAID, YASMINE · 2009 to 2025
$22.4M
Intramural NIH HHS Z99 AI999999Intramural NIH HHS ZIA AI001115
6 · The paper itself

Abstract

The microbiota plays a fundamental role in the induction, education, and function of the host immune system. In return, the host immune system has evolved multiple means by which to maintain its symbiotic relationship with the microbiota. The maintenance of this dialogue allows the induction of protective responses to pathogens and the utilization of regulatory pathways involved in the sustained tolerance to innocuous antigens. The ability of microbes to set the immunological tone of tissues, both locally and systemically, requires tonic sensing of microbes and complex feedback loops between innate and adaptive components of the immune system. Here we review the dominant cellular mediators of these interactions and discuss emerging themes associated with our current understanding of the homeostatic immunological dialogue between the host and its microbiota.

Indexed as

Adaptive ImmunityAnimalsHomeostasisHost-Pathogen InteractionsHumansImmune SystemImmune ToleranceImmunity, InnateMicrobiotaModels, Immunological

Identifiers

PMID28423337
PMCPMC5604871

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.